1. Home
  2. VHUB vs NSPR Comparison

VHUB vs NSPR Comparison

Compare VHUB & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VenHub Global Inc. Common Stock

VHUB

VenHub Global Inc. Common Stock

N/A

Current Price

$0.19

Market Cap

36.0M

Sector

N/A

ML Signal

N/A

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.63

Market Cap

38.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
VHUB
NSPR
Founded
2000
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.0M
38.9M
IPO Year
2025
2009

Fundamental Metrics

Financial Performance
Metric
VHUB
NSPR
Price
$0.19
$0.63
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $2.67
AVG Volume (30 Days)
129.1K
★ 408.2K
Earning Date
11-16-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
$864,450.00
★ $2,310,000.00
Revenue This Year
N/A
$9.38
Revenue Next Year
N/A
$67.09
P/E Ratio
N/A
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$0.19
$0.43
52 Week High
$15.34
$2.17

Technical Indicators

Market Signals
Indicator
VHUB
NSPR
Relative Strength Index (RSI) 23.74 49.62
Support Level N/A $0.43
Resistance Level $0.29 $0.79
Average True Range (ATR) 0.03 0.12
MACD 0.01 0.00
Stochastic Oscillator 2.29 45.95

Price Performance

Historical Comparison
VHUB
NSPR

About VHUB VenHub Global Inc. Common Stock

Venhub Global Inc is engaged in designing and building autonomous Smart Stores that operate 24/7 without on-site staff. Each store combines robotic automation, real-time inventory tracking, and mobile-based checkout to provide secure, convenient retail access, and is offered as an integrated retail solution to store operators.

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

Share on Social Networks: